Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio-Techne (TECH) EBIT Margin (2016 - 2025)

Bio-Techne (TECH) has 17 years of EBIT Margin data on record, last reported at 18.41% in Q4 2025.

  • For Q4 2025, EBIT Margin rose 244.0% year-over-year to 18.41%; the TTM value through Dec 2025 reached 9.62%, down 712.0%, while the annual FY2025 figure was 8.38%, 945.0% down from the prior year.
  • EBIT Margin reached 18.41% in Q4 2025 per TECH's latest filing, up from 16.63% in the prior quarter.
  • Across five years, EBIT Margin topped out at 2815.85% in Q3 2022 and bottomed at 7.53% in Q2 2025.
  • Average EBIT Margin over 5 years is 159.34%, with a median of 21.13% recorded in 2023.
  • Peak YoY movement for EBIT Margin: soared 279132bps in 2022, then plummeted -279568bps in 2023.
  • A 5-year view of EBIT Margin shows it stood at 23.15% in 2021, then increased by 8bps to 25.0% in 2022, then tumbled by -44bps to 13.94% in 2023, then grew by 15bps to 15.96% in 2024, then increased by 15bps to 18.41% in 2025.
  • Per Business Quant database, its latest 3 readings for EBIT Margin were 18.41% in Q4 2025, 16.63% in Q3 2025, and 7.53% in Q2 2025.